Select your timezone:

Campfire Session
Transplant immunosuppression

Monday September 12, 2022 | 17:35 to 18:35
Room: CF-6
Track: Transplantation Immunosuppression


For attending this session, you can claim 1 EACCME credits


Mr. Niels L. Riemersma, Netherlands
Tremor, daily functioning, and quality of life in solid organ transplant recipients

Dr. Prasad Gurjar, India
CYP3A5 polymorphism in renal transplantation: a key to personalized medicine

Dr. Samy M Riad, United States
Outcomes of Dialysis Dependent Second Kidney Transplant Recipients by Induction Type in the United States

Miss Karen Sofia K Gonzalez Arazo, Argentina
Belatacept vs. Tacrolimus in the real world. An efficacy and safety analysis

Prof. Wenhan Peng, People's Republic of China
Efficacy and safety of an intensified dosing regimen of enteric-coated mycophenolate sodium in de novo kidney transplant recipients in China: a prospective cohort study

Dr. Elisa Cerri, Argentina
Belatacept as primary immunosuppression in patients with cardiac transplantation

Dr. Hatem Ali, United Kingdom
Is incidence of post-transplant diabetes mellitus higher with adoport compared to prograf in patients post renal transplantation?

Dr. Christophe Masset, France
Very low dose Anti-Thymocyte Globulins versus Basiliximab in non-immunized kidney transplant recipients

© 2024 TTS 2022